Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1992 Feb;67(2):155–160. doi: 10.1136/hrt.67.2.155

Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy.

M Shimizu 1, N Sugihara 1, Y Kita 1, K Shimizu 1, Y Horita 1, K Nakajima 1, J Taki 1, R Takeda 1
PMCID: PMC1024746  PMID: 1540436

Abstract

OBJECTIVE--To investigate the relation between regional myocardial sympathetic nerve activity and the electrocardiographic and cardiac functional changes in hypertrophic cardiomyopathy. DESIGN--A retrospective study to compare the findings of myocardial scintigraphy with iodine-123 metaiodobenzylguanidine (MIBG) and the serial electrocardiographic changes. SETTING--Myocardial scintigraphy was performed with iodine-123 MIBG and thallium-201 and single photon emission computed tomography (SPECT) in the division of nuclear medicine of Kanazawa University Hospital. Both SPECT studies were performed within a week. PATIENTS--22 patients with hypertrophic cardiomyopathy classified according to their serial electrocardiographic changes--namely, 15 patients with an increase in or the appearance of a negative T wave (group A) and seven patients with a conduction disturbance or a decrease in or disappearance of the negative T wave (group B). The mean follow up period was 45 (range 12-143) months. RESULTS--Group B showed a high rate of decreased activity or defects in MIBG uptake compared with group A (p less than 0.005). The areas of decreased activity or defects corresponded with the hypertrophied portion of the left ventricular wall. Although the early myocardial uptake (MIBG: thallium ratio) was similar in both groups, the mean (SD) MIBG clearance rate was significantly higher (p less than 0.05) in group B (0.25 (0.17)) than in group A (0.10 (0.15)). CONCLUSION--Abnormalities of regional myocardial sympathetic nerve activity may be important in patients with hypertrophic cardiomyopathy and suspected progression of myocardial damage.

Full text

PDF
155

Images in this article

157Image
on p.157
157Image
on p.157

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beder S. D., Gutgesell H. P., Mullins C. E., McNamara D. G. Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child. Am Heart J. 1982 Jul;104(1):155–156. doi: 10.1016/0002-8703(82)90654-8. [DOI] [PubMed] [Google Scholar]
  2. Campbell M., Summerell J. M., Bras G., Hayes J. A., Stuart K. L. Pathology of idiopathic cardiomegaly in Jamaica. Br Heart J. 1971 Mar;33(2):193–202. doi: 10.1136/hrt.33.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fujiwara H., Onodera T., Tanaka M., Shirane H., Kato H., Yoshikawa J., Osakada G., Sasayama S., Kawai C. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage. Jpn Circ J. 1984 Nov;48(11):1210–1214. doi: 10.1253/jcj.48.1210. [DOI] [PubMed] [Google Scholar]
  4. Funakoshi M., Imamura M., Sasaki J., Fujino M., Kawano T., Sasaki Y., Nakashima Y., Motooka T., Fukuda K., Imagawa M. Seventeen year follow-up of a patient with hypertrophic cardiomyopathy which progressed to dilated cardiomyopathy. Jpn Heart J. 1984 Sep;25(5):805–809. doi: 10.1536/ihj.25.805. [DOI] [PubMed] [Google Scholar]
  5. Geisterfer-Lowrance A. A., Kass S., Tanigawa G., Vosberg H. P., McKenna W., Seidman C. E., Seidman J. G. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990 Sep 7;62(5):999–1006. doi: 10.1016/0092-8674(90)90274-i. [DOI] [PubMed] [Google Scholar]
  6. Henderson E. B., Kahn J. K., Corbett J. R., Jansen D. E., Pippin J. J., Kulkarni P., Ugolini V., Akers M. S., Hansen C., Buja L. M. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation. 1988 Nov;78(5 Pt 1):1192–1199. doi: 10.1161/01.cir.78.5.1192. [DOI] [PubMed] [Google Scholar]
  7. Horita Y., Genda A., Shimizu M., Sugihara N., Suematsu T., Kita Y., Takeda R. Serial electrocardiographic and angiographic changes of patients with hypertrophic cardiomyopathy. Jpn Circ J. 1989 Nov;53(11):1327–1342. doi: 10.1253/jcj.53.1327. [DOI] [PubMed] [Google Scholar]
  8. James T. N., Marshall T. K. De subitaneis mortibus. XII. Asymmetrical hypertrophy of the heart. Circulation. 1975 Jun;51(6):1149–1166. doi: 10.1161/01.cir.51.6.1149. [DOI] [PubMed] [Google Scholar]
  9. Kawai C., Yui Y., Hoshino T., Sasayama S., Matsumori A. Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study. J Am Coll Cardiol. 1983 Nov;2(5):834–840. doi: 10.1016/s0735-1097(83)80229-0. [DOI] [PubMed] [Google Scholar]
  10. Kline R. C., Swanson D. P., Wieland D. M., Thrall J. H., Gross M. D., Pitt B., Beierwaltes W. H. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med. 1981 Feb;22(2):129–132. [PubMed] [Google Scholar]
  11. Maron B. J., Epstein S. E., Roberts W. C. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol. 1979 Jun;43(6):1086–1102. doi: 10.1016/0002-9149(79)90139-5. [DOI] [PubMed] [Google Scholar]
  12. McKenna W. J., Borggrefe M., England D., Deanfield J., Oakley C. M., Goodwin J. F. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation. 1982 Dec;66(6):1233–1240. doi: 10.1161/01.cir.66.6.1233. [DOI] [PubMed] [Google Scholar]
  13. Nagata S., Park Y., Minamikawa T., Yutani C., Kamiya T., Nishimura T., Kozuka T., Sakakibara H., Nimura Y. Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy. Am Heart J. 1985 Jun;109(6):1317–1322. doi: 10.1016/0002-8703(85)90358-8. [DOI] [PubMed] [Google Scholar]
  14. Nakajo M., Shimabukuro K., Yoshimura H., Yonekura R., Nakabeppu Y., Tanoue P., Shinohara S. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med. 1986 Jan;27(1):84–89. [PubMed] [Google Scholar]
  15. O'Gara P. T., Bonow R. O., Maron B. J., Damske B. A., Van Lingen A., Bacharach S. L., Larson S. M., Epstein S. E. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation. 1987 Dec;76(6):1214–1223. doi: 10.1161/01.cir.76.6.1214. [DOI] [PubMed] [Google Scholar]
  16. Pasternac A., Noble J., Streulens Y., Elie R., Henschke C., Bourassa M. G. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation. 1982 Apr;65(4):778–789. doi: 10.1161/01.cir.65.4.778. [DOI] [PubMed] [Google Scholar]
  17. Pitcher D., Wainwright R., Maisey M., Curry P., Sowton E. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Br Heart J. 1980 Dec;44(6):650–656. doi: 10.1136/hrt.44.6.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sisson J. C., Frager M. S., Valk T. W., Gross M. D., Swanson D. P., Wieland D. M., Tobes M. C., Beierwaltes W. H., Thompson N. W. Scintigraphic localization of pheochromocytoma. N Engl J Med. 1981 Jul 2;305(1):12–17. doi: 10.1056/NEJM198107023050103. [DOI] [PubMed] [Google Scholar]
  19. Sisson J. C., Shapiro B., Meyers L., Mallette S., Mangner T. J., Wieland D. M., Glowniak J. V., Sherman P., Beierwaltes W. H. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 1987 Oct;28(10):1625–1636. [PubMed] [Google Scholar]
  20. Sole M. J., Lo C. M., Laird C. W., Sonnenblick E. H., Wurtman R. J. Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster. Circ Res. 1975 Dec;37(6):855–862. doi: 10.1161/01.res.37.6.855. [DOI] [PubMed] [Google Scholar]
  21. Spirito P., Maron B. J., Bonow R. O., Epstein S. E. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol. 1987 Jul 1;60(1):123–129. doi: 10.1016/0002-9149(87)90998-2. [DOI] [PubMed] [Google Scholar]
  22. Tanigawa G., Jarcho J. A., Kass S., Solomon S. D., Vosberg H. P., Seidman J. G., Seidman C. E. A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy chain hybrid gene. Cell. 1990 Sep 7;62(5):991–998. doi: 10.1016/0092-8674(90)90273-h. [DOI] [PubMed] [Google Scholar]
  23. Thompson D. S., Naqvi N., Juul S. M., Swanton R. H., Coltart D. J., Jenkins B. S., Webb-Peploe M. M. Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br Heart J. 1980 Nov;44(5):488–498. doi: 10.1136/hrt.44.5.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Valk T. W., Frager M. S., Gross M. D., Sisson J. C., Wieland D. M., Swanson D. P., Mangner T. J., Beierwaltes W. H. Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med. 1981 Jun;94(6):762–767. doi: 10.7326/0003-4819-94-6-762. [DOI] [PubMed] [Google Scholar]
  25. Weber K. T., Janicki J. S., Shroff S. G., Pick R., Chen R. M., Bashey R. I. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988 Apr;62(4):757–765. doi: 10.1161/01.res.62.4.757. [DOI] [PubMed] [Google Scholar]
  26. Wieland D. M., Brown L. E., Rogers W. L., Worthington K. C., Wu J. L., Clinthorne N. H., Otto C. A., Swanson D. P., Beierwaltes W. H. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981 Jan;22(1):22–31. [PubMed] [Google Scholar]
  27. Wieland D. M., Wu J., Brown L. E., Mangner T. J., Swanson D. P., Beierwaltes W. H. Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine. J Nucl Med. 1980 Apr;21(4):349–353. [PubMed] [Google Scholar]
  28. Yutani C., Imakita M., Ishibashi-Ueda H., Hatanaka K., Nagata S., Sakakibara H., Nimura Y. Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy. Am Heart J. 1985 Mar;109(3 Pt 1):545–553. doi: 10.1016/0002-8703(85)90561-7. [DOI] [PubMed] [Google Scholar]
  29. ten Cate F. J., Roelandt J. Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J. 1979 Jun;97(6):762–765. doi: 10.1016/0002-8703(79)90012-7. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES